Division of Plastic Surgery and Hand Surgery, University Hospital Zurich, Sternwartstrasse 14, 8091 Zurich, Switzerland.
Int J Mol Sci. 2023 Jan 25;24(3):2370. doi: 10.3390/ijms24032370.
Tendon injuries suffer from a slow healing, often ending up in fibrovascular scar formation, leading to inferior mechanical properties and even re-rupture upon resumption of daily work or sports. Strategies including the application of growth factors have been under view for decades. Insulin-like growth factor-1 (IGF-1) is one of the used growth factors and has been applied to tenocyte in vitro cultures as well as in animal preclinical models and to human patients due to its anabolic and matrix stimulating effects. In this narrative review, we cover the current literature on IGF-1, its mechanism of action, in vitro cell cultures (tenocytes and mesenchymal stem cells), as well as in vivo experiments. We conclude from this overview that IGF-1 is a potent stimulus for improving tendon healing due to its inherent support of cell proliferation, DNA and matrix synthesis, particularly collagen I, which is the main component of tendon tissue. Nevertheless, more in vivo studies have to be performed in order to pave the way for an IGF-1 application in orthopedic clinics.
肌腱损伤的愈合速度较慢,往往会导致纤维血管瘢痕形成,导致机械性能下降,甚至在恢复日常工作或运动后再次断裂。几十年来,人们一直在研究包括应用生长因子在内的各种策略。胰岛素样生长因子-1(IGF-1)是一种常用的生长因子,由于其具有合成代谢和基质刺激作用,已被应用于肌腱细胞体外培养以及动物临床前模型和人类患者中。在这篇综述中,我们涵盖了关于 IGF-1 的当前文献,包括其作用机制、体外细胞培养(肌腱细胞和间充质干细胞)以及体内实验。我们从这个综述中得出结论,IGF-1 是一种有效的刺激物,可以改善肌腱愈合,因为它可以促进细胞增殖、DNA 和基质合成,特别是 I 型胶原,它是肌腱组织的主要成分。然而,为了为 IGF-1 在骨科临床中的应用铺平道路,还需要进行更多的体内研究。